Current Report Filing (8-k)
April 22 2016 - 6:11AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event
reported): April 22, 2016 (April 20, 2016)
____________________
Neuralstem, Inc.
(Exact name of registrant as specified
in Charter)
Delaware
|
|
001-33672
|
|
52-2007292
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(Commission File No.)
|
|
(IRS Employee Identification No.)
|
20271 Goldenrod Lane, 2
nd
Floor, Germantown, Maryland 20876
(Address of Principal Executive Offices)
(301) 366-4960
(Issuer Telephone
number)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item
3.01
|
Notice
of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
On April 20, 2016, Neuralstem, Inc. (the
“Company”) received a written notice (the “Notice”) from the NASDAQ Stock Market LLC (“NASDAQ”)
that the Company is not in compliance with NASDAQ Listing Rule 5550(a)(2), as the minimum bid price of the Company’s common
stock has been below $1.00 per share for 30 consecutive business days. The Notice has no immediate effect on the listing of the
Company’s common stock, and its common stock will continue to trade on the NASDAQ Capital Market under the symbol “CUR”
at this time.
In accordance with NASDAQ Listing Rule
5810(c)(3)(A), the Company has a period of 180 calendar days, or until October 17, 2016, to regain compliance with the minimum
bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must meet or exceed $1.00
per share for at least ten consecutive business days during this 180 calendar day period.
In the event the Company does not regain
compliance by October 17, 2016, the Company may be eligible for an additional 180 calendar day grace period if it meets the initial
listing standards, with the exception of bid price, for the NASDAQ Capital Market, and provides written notice to NASDAQ of its
intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the
Company does not regain compliance within the allotted compliance period(s), including any extensions that may be granted by NASDAQ,
NASDAQ will provide notice that the Company’s common stock will be subject to delisting. The Company would then be entitled
to appeal the determination to a NASDAQ Listing Qualifications Panel and request a hearing.
The Company intends to monitor the closing
bid price of its common stock and consider its available options to resolve its noncompliance with the minimum bid price requirement.
No determination regarding the Company’s response to the Notice has been made at this time. There can be no assurance that
the Company will be able to regain compliance with the minimum bid price requirement or will otherwise be in compliance with the
other listing standards for the NASDAQ Capital Market.
A copy of the Company’s press release
dated April 21, 2016, announcing the receipt of the Notice is attached to this report as Exhibit 99.01 and incorporated herein
by reference.
|
Item
9.01
|
Financial
Statement and Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
|
99.01
|
|
Press Release Dated April 21, 2016
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto
duly authorized.
Date:
|
April 22, 2016
|
Neuralstem, Inc.
|
|
|
|
|
|
|
|
|
/s/ Richard Daly
|
|
|
|
By: Richard Daly
|
|
|
Chief Executive Officer
|
INDEX OF EXHIBITS
Exhibit
No.
|
|
Description
|
99.01
|
|
Press Release Dated April 21, 2016
|
Neuralstem (NASDAQ:CUR)
Historical Stock Chart
From May 2024 to Jun 2024
Neuralstem (NASDAQ:CUR)
Historical Stock Chart
From Jun 2023 to Jun 2024